Finckenstein, M.D. Chief Medical Officer · IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Friedrich Graf

A named executive officer of IOVANCE BIOTHERAPEUTICS in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,772,310

Salary $450,000Stock awards $0

FY2019: $3,359,140

4th of 7 named executive officers at Iovance Biotherapeutics by FY2020 total.

7 named officers on file for IOVANCE BIOTHERAPEUTICS, FY2020

Friedrich Graf’s pay file — $29

  • 2 fiscal years of pay, line by line
  • IOVA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IOVANCE BIOTHERAPEUTICS’s whole pay program stands against its peers

  • IOVANCE BIOTHERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IOVA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Friedrich Graf’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Friedrich Graf compensation by year

IOVANCE BIOTHERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as IOVANCE BIOTHERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$450,000$450,000
Bonus$160,000$0
Stock awards$0$0
Option awards$2,655,440$1,220,910
Non-equity incentive$82,500$90,000
Pension and deferred compensation$0$0
All other$11,200$11,400
Total$3,359,140$1,772,310

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IOVANCE BIOTHERAPEUTICS, INC. DEF 14A filed April 27, 2021, accession 0001104659-21-055704, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IOVANCE BIOTHERAPEUTICS, INC. filed document, accession 0001104659-21-055704. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$3.4M
$1.8M
FY19
FY20
SalaryBonusNon-equity incentiveOption awardsAll other

IOVANCE BIOTHERAPEUTICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Maria FardisFormer President and Chief Executive Officer$9,039,400
Jean-Marc BelleminChief Financial Officer$4,570,912
Frederick VogtGeneral Counsel and Corporate Secretary$2,955,553
Friedrich Graf · this pageFinckenstein, M.D. Chief Medical Officer$1,772,310
Friedrich FinckensteinChief Medical Officer$1,772,310
Michael SwartzburgFormer Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer (7)$1,074,896
Timothy MorrisFormer Chief Financial Officer (6)$482,045

The full IOVANCE BIOTHERAPEUTICS compensation record

free company brief

This page is one person within IOVANCE BIOTHERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IOVANCE BIOTHERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IOVANCE BIOTHERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Friedrich Graf's compensation dossier · One-time report. No refunds.